Titre (en)
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « safety »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
safely < safety < sagkeeng  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000101 (2013) Stewart A. Factor [États-Unis] ; Kenneth Wolski [États-Unis] ; Daniel M. Togasaki [États-Unis] ; Susan Huyck [États-Unis] ; Marc Cantillon [États-Unis] ; T. W. Ho [États-Unis] ; Robert A. Hauser [États-Unis] ; Emmanuelle Pourcher [Canada]Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
000125 (2013) K. A. Papp [Canada] ; R. G. Langley [Canada] ; B. Sigurgeirsson [Islande] ; M. Abe [Japon] ; D. R. Baker [États-Unis] ; P. Konno [Estonie] ; S. Haemmerle [Suisse] ; H. J. Thurston [Suisse] ; C. Papavassilis [Suisse] ; H. B. Richards [Suisse]Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study
000162 (2012) Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Günther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis]Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
000759 (2009) P J Mease [États-Unis] ; K. Hobbs [États-Unis] ; A. Chalmers [Canada] ; H. El-Gabalawy [Canada] ; A. Bookman [Canada] ; E. Keystone [Canada] ; D E Furst [États-Unis] ; P. Anklesaria [États-Unis] ; A E Heald [États-Unis]Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study
000D40 (2004) Allan C. Skanes ; Douglas L. Jones ; Patrick Teefy ; Colette Guiraudon [Canada] ; Raymond Yee ; Andrew D. Krahn ; George J. KleinSafety and Feasibility of Cryothermal Ablation Within the Mid‐ and Distal Coronary Sinus
000D66 (2004) Jacqueline Low [Canada]Managing Safety and Risk: The Experiences of People with Parkinson’s Disease who Use Alternative and Complementary Therapies
001099 (2001) Andrew D. Krahn [Canada] ; George J. Klein [Canada] ; Raymond Yee [Canada]A Randomized, Double‐Blind, Placebo‐Controlled Evaluation of the Efficacy and Safety of Intravenously Administered Dofetilide in Patients with Wolff‐Parkinson‐White Syndrome
001246 (2000) Lionel H. Opie [Allemagne] ; Salim Yusuf [Allemagne] ; Wolfgang Kübler [Allemagne, Afrique du Sud]Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: A critical analysis based on 100 studies
001352 (1999) Rajeev Kumar [Canada] ; Robert Chen [Canada] ; Peter Ashby [Canada]Safety of transcranial magnetic stimulation in patients with implanted deep brain stimulators
001500 (1998) Amit M. Vora Md [Canada] ; Martin S. Green Md [Canada] ; Anthony S. L Tang Md [Canada]Safety and Feasibility of Same Day Discharge in Patients Undergoing Radiofrequency Catheter Ablation
001822 (1996) J. A. Addison [Canada]Safety Testing of Tebufenozide, a New Molt-Inducing Insecticide, for Effects on Nontarget Forest Soil Invertebrates
001B93 (1994) Felicia H. Figa [Canada] ; Robert M. Gow [Canada] ; Robert M. Hamilton [Canada] ; Robert M. Freedom [Canada]Clinical efficacy and safety of intravenous amiodarone in infants and children
001F80 (1991) Marion Tipple [Canada] ; George Sandor [Canada]Efficacy and Safety of Oral Sotalol in Early Infancy
002316 (1987) Mohammad Shenasa [Canada] ; Martin Fromer [Canada] ; Gerard Faugere [Canada] ; Reginald Nadeau [Canada] ; Robert A. Leblanc [Canada] ; Chantal Lambert [Canada] ; Mohammad Ali Sadr-Ameli [Canada]Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome
002533 (1985) Gideon Koren [Canada] ; Warwick Butt [Canada] ; Herbert Chinyanga [Canada] ; Steven Soldin [Canada] ; Yok-Kwang Tan [Canada] ; Karen Pape [Canada]Postoperative morphine infusion in newborn infants: Assessment of disposition characteristics and safety

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "safety" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "safety" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    safety
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022